✦ LIBER ✦

High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers

✍ Scribed by Kun-Huei Yeh; Ming-Tseh Lin; Dong-Tsamn Lin; Jih-Luh Tang; Louis-Tak Lui; Jing-Fang Lin; Yu-Shiahn Chang; Ann-Lii Cheng; Sen-Chang Yu; King-Jen Chang; Yao-Chang Chen

Book ID: 110231388
Publisher: Springer US
Year: 1998
Tongue: English
Weight: 577 KB
Volume: 49
Category: Article
ISSN: 0167-6806
DOI: 10.1023/a:1006023731381

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant high-dose therapy with peripher

Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancer

✍ S. Hohaus; S. Martin; A. Schneeweiß; M. T. Voso; R. F. Schlenk; D. Wallwiener; G 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 105 KB

High-dose doxorubicin, etoposide, and cy

High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer

✍ George Somlo; James H. Doroshow; Stephen J. Forman; Lucille A. Leong; Kim A. Mar 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 780 KB

High-dose cisplatin, etoposide, and cycl

High-dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high-risk primary breast cancer

✍ George Somlo; James H. Doroshow; Stephen J. Forman; Lucille A. Leong; Kim A. Mar 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 901 KB

Induction, mobilization of peripheral bl

Induction, mobilization of peripheral blood stem cells (PBSC), high-dose chemotherapy and PBSC infusion in patients with untreated stage IV breast cancer: outcomes by intent to treat analyses

✍ Weaver, C H; West, W H; Schwartzberg, L S; Alberico, T; Leff, R; Greco, F A; Hai 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 133 KB

P53 is the strongest predictor of surviv

P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support

✍ Manfred Hensel; Andreas Schneeweiss; Hans-Peter Sinn; Gerlinde Egerer; Erich Sol 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 129 KB 👁 3 views

## Abstract Our purpose was to determine the predictive value of tumor biologic parameters in patients with HRPBC who received HDCT with ASCT as first‐line treatment. From September 1992 to May 2000, 149 stage II or III HRPBC patients were enrolled in a single‐arm trial using a tandem HDCT regimen

Cardiac sequelae of doxorubicin and pacl

Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer

✍ Klein, J L; Rey, P Maroto; Dansey, R D; Karanes, C; Du, W; Abella, E; Cassells, 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 69 KB